In the increasingly volatile world of international trade, the term Most-Favoured Nation (MFN) is gaining renewed attention. This comes after the US, under President Donald Trump, imposed sweeping new ...

A proposed US most-favored nation (MFN) drug-pricing rule is adding a new source of uncertainty to healthcare dealmaking, prompting private equity investors to reassess exposure to pharma, ...

On 8 August 2022, the UK’s Competition Appeal Tribunal (CAT) unanimously set aside a £17.9 million fine imposed on the Compare The Market website (CTM) by the Competition and Markets Authority (CMA).

The Trump Administration has announced its desire to impose price controls on drugs – officially called a most favored nation (MFN) policy. Essentially, the policy sets the price for the targeted ...

On July 31, the Trump administration called on drug manufacturers to lower prescription drug prices in the U.S. to "most favored nation" – or MFN – pricing, the lowest cost paid for the same ...

I will conclude this series of posts by considering the variants of MFN that affect the way strict scrutiny is applied. MFN-6, ubiquitous in the Covid cases, makes strict scrutiny impossible to ...

At first glance “Most Favoured Nation” evokes trade accords and diplomatic parlance rather than a studio. Yet within the tapestry of music‑industry contracts, an MFN clause is a bulwark against ...

The MFN executive order seeks to align US drug prices with those in other developed countries, recently advancing through a voluntary agreement with Pfizer. Legal and procedural challenges exist, with ...

The Trump administration’s announcement of the first MFN agreement is a major drug pricing policy milestone. Industry and policymakers await the release of the administration’s Global Benchmark for ...